HomeCompareNENTF vs JNJ

NENTF vs JNJ: Dividend Comparison 2026

NENTF yields 1427.55% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NENTF wins by $447599888.29M in total portfolio value
10 years
NENTF
NENTF
● Live price
1427.55%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$447599888.32M
Annual income
$393,391,018,072,924.75
Full NENTF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — NENTF vs JNJ

📍 NENTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNENTFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NENTF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NENTF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NENTF
Annual income on $10K today (after 15% tax)
$121,341.90/yr
After 10yr DRIP, annual income (after tax)
$334,382,365,361,986.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, NENTF beats the other by $334,382,365,358,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NENTF + JNJ for your $10,000?

NENTF: 50%JNJ: 50%
100% JNJ50/50100% NENTF
Portfolio after 10yr
$223799944.17M
Annual income
$196,695,509,038,807.06/yr
Blended yield
87.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NENTF
No analyst data
Altman Z
1.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NENTF buys
0
JNJ buys
0
No recent congressional trades found for NENTF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNENTFJNJ
Forward yield1427.55%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$447599888.32M$30.3K
Annual income after 10y$393,391,018,072,924.75$4,689.40
Total dividends collected$443633473.03M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NENTF vs JNJ ($10,000, DRIP)

YearNENTF PortfolioNENTF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$153,455$142,755.17$10,592$272.30+$142.9KNENTF
2$2,211,535$2,047,338.35$11,289$357.73+$2.20MNENTF
3$29,941,513$27,575,169.94$12,123$472.89+$29.93MNENTF
4$380,948,102$348,910,682.83$13,141$629.86+$380.93MNENTF
5$4,556,415,078$4,148,800,609.56$14,408$846.81+$4556.40MNENTF
6$51,251,680,747$46,376,316,613.08$16,021$1,151.60+$51251.66MNENTF
7$542,364,764,825$487,525,466,425.79$18,122$1,588.22+$542364.75MNENTF
8$5,401,993,643,144$4,821,663,344,781.63$20,930$2,228.20+$5401993.62MNENTF
9$50,662,495,555,229$44,882,362,357,064.57$24,792$3,191.91+$50662495.53MNENTF
10$447,599,888,317,020$393,391,018,072,924.75$30,274$4,689.40+$447599888.29MNENTF

NENTF vs JNJ: Complete Analysis 2026

NENTFStock

Viaplay Group AB (publ) operates as an entertainment provider and streaming company in Sweden, Norway, Denmark, Finland, the United Kingdom, the Netherlands, and internationally. The company operates Viaplay, an online video streaming service, which offers live sports, original series, documentaries and films, and international TV releases, as well as all-time classic series, and children's animation and series; Viafree that offers a range of free-to-view content to viewers; V sport, series & film, a family of premium-TV channels that offers television entertainment; and Viaplay studios that consists of production companies, which produce original and animated content. It also operates TV3, commercial TV channel; TV6, a young male skewed channel; TV8, a channel that provides procedural drama; TV10, a channel for sporting events and documentaries; Viasat4 and TV3+ for young male audiences; TV3 PULS that offers procedural series, cooking, and lifestyle shows; TV3 Sport for sports lovers; and TV3 MAX, which shows comedy and drama series. In addition, it operates radio stations, comprising of Rix FM, Bandit Rock, Power Hit Radio, Star FM, P4 Lyden av Norge, P5 Hits, P6 Rock, P7 Klem, P8 Pop, P9 Retro, and P10 Country; NRJ, an online TV channel; Bandit, an online station; and I LIKE RADIO, an online music service, well as news, talk shows, and contests. Further, the company offers advertising services on TV channels, radio stations, and streaming services. The company was formerly known as Nordic Entertainment Group AB (publ) and changed its name to Viaplay Group AB (publ) in May 2022. Viaplay Group AB (publ) was incorporated in 2017 and is headquartered in Stockholm, Sweden.

Full NENTF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this NENTF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NENTF vs SCHDNENTF vs JEPINENTF vs ONENTF vs KONENTF vs MAINNENTF vs ABBVNENTF vs MRKNENTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.